Go Pro
OTCMKTS:MKGAF

Merck KGaA (MKGAF) Stock Price, News & Analysis

Merck KGaA logo
$161.21 -0.24 (-0.15%)
As of 03:52 PM Eastern

About Merck KGaA Stock (OTCMKTS:MKGAF)

Advanced

Key Stats

Today's Range
$161.21
$163.11
50-Day Range
$128.12
$174.77
52-Week Range
$116.68
$175.56
Volume
220 shs
Average Volume
622 shs
Market Capitalization
$20.83 billion
P/E Ratio
24.61
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Merck KGaA Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
29th Percentile Overall Score

MKGAF MarketRank™: 

Merck KGaA scored higher than 29% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Merck KGaA.

  • Earnings Growth

    Earnings for Merck KGaA are expected to grow by 8.21% in the coming year, from $9.75 to $10.55 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Merck KGaA is 24.61, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 45.96.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Merck KGaA is 24.61, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.39.

  • Price to Book Value per Share Ratio

    Merck KGaA has a P/B Ratio of 0.76. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Merck KGaA's valuation and earnings.
  • Percentage of Shares Shorted

    0.69% of the float of Merck KGaA has been sold short.
  • Short Interest Ratio / Days to Cover

    Merck KGaA has a short interest ratio ("days to cover") of 491.18, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Merck KGaA has recently decreased by 7.02%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Merck KGaA does not currently pay a dividend.

  • Dividend Growth

    Merck KGaA does not have a long track record of dividend growth.

  • News Coverage This Week

    MarketBeat has tracked 1 news article for Merck KGaA this week, compared to 1 article on an average week.
Receive MKGAF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Merck KGaA and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MKGAF Stock News Headlines

Merck KGaA (OTCMKTS:MKGAF) Sets New 52-Week High - Here's Why
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now.tc pixel
See More Headlines

MKGAF Stock Analysis - Frequently Asked Questions

Merck KGaA's stock was trading at $147.60 at the start of the year. Since then, MKGAF stock has increased by 9.2% and is now trading at $161.21.

Shares of MKGAF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
7/09/2026
Next Earnings (Estimated)
8/06/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:MKGAF
CIK
N/A
Employees
62,908
Year Founded
1891

Profitability

EPS (Trailing Twelve Months)
$6.81
Trailing P/E Ratio
24.61
Forward P/E Ratio
16.53
P/E Growth
N/A
Net Income
$3.06 billion
Net Margins
12.60%
Pretax Margin
15.64%
Return on Equity
10.17%
Return on Assets
5.74%

Debt

Debt-to-Equity Ratio
0.27
Current Ratio
1.31
Quick Ratio
0.84

Sales & Book Value

Annual Sales
$22.72 billion
Price / Sales
0.92
Cash Flow
$48.56 per share
Price / Cash Flow
3.32
Book Value
$212.00 per share
Price / Book
0.76

Miscellaneous

Outstanding Shares
129,240,000
Free Float
N/A
Market Cap
$20.83 billion
Optionable
Not Optionable
Beta
0.96

Social Links

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

This page (OTCMKTS:MKGAF) was last updated on 7/9/2026 by MarketBeat.com Staff.
From Our Partners